Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study

OBJECTIVE: To compare the efficacy and safety of treatment with infliximab plus methotrexate with methotrexate alone in methotrexate-naive patients with active psoriatic arthritis (PsA). METHODS: In this open-label study, patients 18 years and older with active PsA who were naive to methotrexate and...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Baranauskaite, Asta, Raffayová, Helena, Kungurov, NV, Kubanova, Anna, Venalis, Algirdas, Helmle, Laszlo, Srinivasan, Shankar, Nasonov, Evgeny, Vastesaeger, Nathan
Format: Artigo
Jezik:Inglês
Izdano: BMJ Group 2011
Teme:
Clinical and Epidemiological Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3298666/
https://ncbi.nlm.nih.gov/pubmed/21994233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2011.152223
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items